# Silodosin, Tadalafil Alone vs. Silodosin Plus Tadalafil as MET for Lower Ureteric Stones

> **NCT05789732** · NA · COMPLETED · sponsor: **Benha University** · enrollment: 168 (actual)

## Conditions studied

- Lower Ureteric Stones
- Medical Expulsive Therapy
- Tadalafil
- Silodosin

## Interventions

- **DRUG:** Placebo
- **DRUG:** Silodosin
- **DRUG:** Tadalafil
- **DRUG:** Silodosin and Tadalafil

## Key facts

- **NCT ID:** NCT05789732
- **Lead sponsor:** Benha University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-30
- **Primary completion:** 2022-08-30
- **Final completion:** 2022-08-30
- **Target enrollment:** 168 (ACTUAL)
- **Last updated:** 2023-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05789732

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05789732, "Silodosin, Tadalafil Alone vs. Silodosin Plus Tadalafil as MET for Lower Ureteric Stones". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05789732. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*